Evaluation of the Natural Immunity in Pups Inoculated with a Modified-Live Canine Parvovirus Type 2B (CPV-2b) Strain

References

• Von Pirquet C. Das verhalten der kutanine tuberkulinreaktion der masern. Dtsch. Med. Wochenschr. 1908; 34: 1297
   Google Scholar
• Ploegh H. L. Viral strategies of immune evasion. Science 1998; 280: 248
   PubMed Web of Science ®Google Scholar
• Couch R. B. Vaccines, in Clinical Immunology Principles and Practice, R. R. Rich. Mosby, St. Louis 1998; 1: 594
   Google Scholar
• Phillips T. R., Jensen J. L., Rubino M. J. Effects of vaccines on the canine immune system. Can. J. Vet. Res. 1989; 53: 154
   PubMedGoogle Scholar
• Eugster A. K., Nairn C. Diarrhea in puppies: parvovirus-like particles demonstrated in their feces. South West Vet. 1977; 30: 50
   Google Scholar
• Buonavoglia C., Compagnucci M., Orfei Z. Dog response to plaque variant to canine parvovirus. Zentralbl. Veterinarmed. 1983; 30: 526
   Google Scholar
• Carmichael L. E., Joubert J. C., Pollock R. V.H. A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response. Cornell Vet. 1981; 71: 408
   PubMedGoogle Scholar
• McCullough B., Krakowka S., Koestner A. Experimental canine distemper virus-induced lymphoid depletion. Am. J. Pathol. 1974; 74: 155
   PubMedGoogle Scholar
• Krakowka S., Koestner A. Comparison of canine distemper virus strains in gnotobiotic dogs: effects on lymphoid tissues. Am. J. Vet. Res. 1977; 38: 1919
   PubMedGoogle Scholar
• Krakowka S., Cockerell G., Koestner A. Intradermal mitogen response in dogs: correlation with outcome of infection by canine distemper virus. Am. J. Vet. Res. 1977; 38: 1539
   PubMedGoogle Scholar
• Olsen C. G., Stiff M. I., Olsen R. G. Comparison of the blastogenic response of peripheral blood lymphocytes from canine parvovirus-positive and negative outbred dogs. Vet. Immunol. Immunopathol. 1984; 6: 285
   PubMedGoogle Scholar
• Mastro J. M., Axthelm M., Mathes L. E. Repeated suppression of lymphocyte blastogenesis following vaccinations of CPV-immune dogs with modified-live CPV vaccines. Vet. Microbiol. 1986; 12: 201
   PubMedGoogle Scholar
• Sagazio P., Tempesta M., Buonavoglia D. Le varianti antigeniche del parvovirus del cane: un problema emergente. Veterinaria 1998; 12: 41
   Google Scholar
• Sagazio P., Tempesta M., Buonavoglia D. Antigenic relationship between CPV-2 and CPV-2b: results of a serological study. Proceedings 1° International Meeting on Virology of Carnivores, Utrecht, 1998, 43
   Google Scholar
• Buonavoglia C., Pratelli A., Tempesta M. Valutazione delle caratteristiche di innocuità e immunogenicità di una variante 2b di parvovirus del cane (CPV-2b). Veterinaria 1998; 6: 55
   Google Scholar
• Aubert A. Innocuity and activity of a new CPV-2b vaccine in young pups. Meeting on Canine Infectious Disease: from clinics to molecular pathogenesis, Cornell University, IthacaUSA, 1999; 37
   Google Scholar
• Pratelli A., Cavalli A., Normanno G. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). J. Vet. Med. B, in press
   Google Scholar
• Carmichael L. E., Joubert J. C., Pollock R. V.H. Hemagglutination by canine parvovirus: serologic studies and diagnostic applications. Am. J. Vet. Res. 1980; 41: 784
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Lab. Invest. 1968; 21: 77
   PubMed Web of Science ®Google Scholar
• Kumagai K., Itoh K., Hinuma S. Pretreatment of plastic petri dishes with foetal calf serum. A simple method for macrophage isolation. J. Immunol. Meth. 1979; 29: 17
   PubMed Web of Science ®Google Scholar
• Mandell G. L., Hook E. W. Leucocyte function in chronic granulomatous disease of childhood. Am. J. Med. 1969; 47: 473
   PubMed Web of Science ®Google Scholar
• Tagliabue A., Villa L., Boraschi D. Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J. Immunol. 1985; 135: 4178
   PubMed Web of Science ®Google Scholar
• Antonaci S., Tortorella C., De Simone C. Role of bacterial lipopolysaccharides in the development of natural anti-bacterial activity mediated by human peripheral blood T lymphocytes. Intern. Rev. Immunol. 1990; 6: 237
   PubMedGoogle Scholar
• Price D. A., Meier U. C., Klenerman P. The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection. J. Mol. Med. 1998; 76: 699
   PubMedGoogle Scholar
• Spriggs M. K. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol 1996; 14: 101
   PubMed Web of Science ®Google Scholar
• Jerome K. R., Tait J. F., Koelle D. M. Herpes simplex virus type 1 renders infected cells resistent to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 1998; 72: 436
   PubMedGoogle Scholar
• Tewari M., Telford W. G., Miller R. A. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 1995; 270: 22705
   PubMedGoogle Scholar
• Trapani J. A., Sutton V. R., Smyth M. J. CTL granules evolution of vesicles essential for combating virus infections. Immunol. Today 1999; 20: 351
   PubMedGoogle Scholar
• Kledal T. N., Rosenkilde M. M., Coulin F. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated Herpes virus. Science 1997; 277: 1656
   PubMed Web of Science ®Google Scholar
• Price D. A., Klenerman P., Booth B. L. Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol. Today 1999; 20: 212
   PubMedGoogle Scholar
• Carman P. S., Povey R. C. Pathogenesis of canine parvovirus-2 in dogs: haematology, serology and virus recovery. Res. Vet. Sci. 1985; 38: 134
   PubMedGoogle Scholar
• Carman P. S., Povey R. C. Pathogenesis of canine parvovirus-2 in dogs: histopathology and antigen identification in tissues. Res. Vet. Sci. 1985; 38: 141
   PubMedGoogle Scholar
• Bodey G. P., Fainstein V. Candidiasis. Raven Press, New York 1985
   Google Scholar
• Tagliabue A., Nencioni L., Villa L. Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature 1983; 306: 184
   PubMed Web of Science ®Google Scholar
• Jirillo E., Greco B., Caradonna L. Immunological effects following administration of interferon-a in patients with chronic hepatitis C virus (HCV) infection. Immunopharmacol. Immunotoxicol. 1996; 18: 355
   PubMedGoogle Scholar
• Altamura M., Geronimo M. G., Nappi L. Successful treatment of herpes simplex virus (HSV) recurrent genital infection with recombinant human (Rh) granulocyte-macrophage colony stimulating factor (GM-CSF): a case report. Immunopharmacol. Immunotoxicol 1997; 19: 425
   PubMed Web of Science ®Google Scholar